Chief Medical Officer
Dr. Marc Penn directs the medical research of Tissue Genesis. In addition, Dr. Penn is CEO of Black Beret Life Sciences, providing oversight and management of the life sciences investments of the Bosarge Family Office and the executive teams of the portfolio companies in the areas of regenerative medicine, anti-aging and immune therapies.
Dr. Penn completed his Ph.D. in Biomedical Engineering in 1989 and Doctor of Medicine in 1994 at Case Western Reserve University. He served in numerous cardiology positions with the Cleveland Clinic (2000-2011) including as Director of the Coronary Intensive Care Unit, Director of the Experimental Animal Laboratory, Director of the Bakken Heart-Brain Institute and Founding Director of the Center for Cardiovascular Cell Therapy.
Dr. Penn was recognized as one of the Top 50 Doctors in the History of the Cleveland Clinic (MedCity News, Dec. 2011). He has organized and lectured at international symposia and conferences and is author or co-author of hundreds of published articles, abstracts, book chapters and books on a wide range of topics in basic and translational science, and clinical medicine.